$2.84 Million
21.5 Thousand
0.17%
$124
John Paulson acquired 21.5 Thousand Intra-Cellular Therapies shares worth $2.84 Million. That's 0.17% of their equity portfolio (14th largest holding). The stake costed the investor $2.67 Million, netting the investor a gain of 6.3% so far.
Easily embed the chart on your blog or website – it will always update automatically!